| Full Name | Rural Health, Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | 513 N Main St, Anna, Illinois |
| Authorized Official Name and Position | Cynthia K Flamm (CEO) |
| Authorized Official Contact | 6188334471 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Rural Health, Inc. 513 N Main St Anna IL 62906-1668 Ph: (618) 833-4471 | Rural Health, Inc. 513 N Main St Anna IL 62906-1668 Ph: (618) 833-4471 |
| NPI Number | 1982666384 |
|---|---|
| Provider Enumeration Date | 04/03/2006 |
| Last Update Date | 04/25/2016 |
| Medicare PECOS PAC ID | 6800705427 |
|---|---|
| Medicare Enrollment ID | O20040518000240 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982666384 | NPI | - | NPPES |
| 055761 | Other | IL | HEALTH ALLIANCE |
| L1001082 | Other | IL | TRICARE |
| 111760 | Other | IL | HEALTHLINK |
| 9115000 | Other | IL | BCBS ANNA |
| L1001082 | Other | IL | CHAMPVA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | (* (Not Available)) | Secondary |
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
| Provider Name | Sherry L Jones |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1912908906 PECOS PAC ID: 1557356789 Enrollment ID: I20040417000233 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Karen A Strack |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1700855871 PECOS PAC ID: 7719890839 Enrollment ID: I20061019000382 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | William Gerard Ribbing |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1245238625 PECOS PAC ID: 2264341882 Enrollment ID: I20100611000168 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Christine M Lucas |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1346248374 PECOS PAC ID: 6709901861 Enrollment ID: I20100913000544 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Amanda J Bowers |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942620372 PECOS PAC ID: 3870719255 Enrollment ID: I20140721000653 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Megan Walker |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1013464692 PECOS PAC ID: 2860773280 Enrollment ID: I20161227000234 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Cynthia K Flamm |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1891223533 PECOS PAC ID: 4183700800 Enrollment ID: I20170605002594 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Alison M Brown |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1609302165 PECOS PAC ID: 6608145396 Enrollment ID: I20170712001831 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Keith Bass |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114440179 PECOS PAC ID: 7517230014 Enrollment ID: I20170905002980 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Emily Hawkins |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871076703 PECOS PAC ID: 5698013423 Enrollment ID: I20190220002114 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Katherine Painter |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1295171023 PECOS PAC ID: 0648569335 Enrollment ID: I20190405001107 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Erica Vining |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306303292 PECOS PAC ID: 5092057141 Enrollment ID: I20190422001264 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Olivia J Hand |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1316599442 PECOS PAC ID: 8123354859 Enrollment ID: I20190801002172 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Rachael Wernsman |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1417590639 PECOS PAC ID: 9133451743 Enrollment ID: I20191031002403 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Robert Dale Arnold |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1891915609 PECOS PAC ID: 1557666567 Enrollment ID: I20200117000027 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Morgan N Atherton |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1609414069 PECOS PAC ID: 7719313972 Enrollment ID: I20200206000535 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Theresa Bainbridge |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1639797624 PECOS PAC ID: 5698190262 Enrollment ID: I20200730001741 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Marla Williams |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1033764881 PECOS PAC ID: 5597183996 Enrollment ID: I20200917000301 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Brent S Jakubec |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497175251 PECOS PAC ID: 3870901259 Enrollment ID: I20210423001785 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Dennis Edward Gade |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1952066656 PECOS PAC ID: 4880085539 Enrollment ID: I20220106002554 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Maria Barbagallo |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1669127312 PECOS PAC ID: 5294120077 Enrollment ID: I20220314000872 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Russell Gene Boester |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1982621686 PECOS PAC ID: 2769878743 Enrollment ID: I20220330001949 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Michael Peter Holub |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1134266620 PECOS PAC ID: 6305227695 Enrollment ID: I20220718003009 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Morgan Leigh Torrez |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1700371762 PECOS PAC ID: 6305190653 Enrollment ID: I20220720002125 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Raymond C Otte |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1063632818 PECOS PAC ID: 4587040951 Enrollment ID: I20221008000058 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Knichole Leanne Keeling |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487359394 PECOS PAC ID: 0244699767 Enrollment ID: I20230630002414 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Jennifer Ting |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1912687336 PECOS PAC ID: 9133582091 Enrollment ID: I20230825001615 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
| Provider Name | Alaa Alshair |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1508519281 PECOS PAC ID: 3577919364 Enrollment ID: I20231031001586 |
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago
News Archive
Researchers with Dartmouth Medical School and the Veterans Affairs Outcomes Group at the White River Junction (Vt.) VA Medical Center are questioning the usefulness of the C-Reactive Protein (CRP) test for guiding decisions about the use of cholesterol-lowering medication.
"Now, with a leader of the [Muslim] Brotherhood's political arm in Egypt's presidential palace and its members dominating Parliament, some deeply patriarchal views the organization has long taught its members are spilling into public view," the New York Times reports, noting a statement released this week by the Brotherhood objecting to "a proposed United Nations declaration to condemn violence against women."
A team of scientists recently conducted a study to examine whether natural infection-induced or vaccine-induced neutralizing antibodies are capable of eliminating the risk of recently emerged Indian variant (B.1.617.1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.
› Verified 1 days ago